• Home
  • News

Pfizer Animal Health To Present New Data Identifying Pathways Of Canine Allergic Skin Diseases At 2012 Meeting Of World Congress Of Veterinary Dermatology

Wednesday, July 25, 2012 8:08 am EDT


VANCOUVER, British Columbia
"Current Understanding of the Pathophysiologic Mechanisms of Canine Atopic Dermatitis"

VANCOUVER, British Columbia--Pfizer Animal Health will present data from discovery studies validating specific pathways of allergic skin disease in dogs and studies evaluating novel molecules targeting these pathways at the 7th World Congress of Veterinary Dermatology (WCVD) Meeting 2012 in Vancouver, British Columbia, from July 24–28. Approximately six presentations related to Pfizer’s research and development program in veterinary dermatology are scheduled.

“Pfizer Animal Health is committed to advancing research in veterinary dermatology,” said Candace Sousa, DVM, DABVP, DACVD, a dermatologist and senior veterinary specialist with the Pfizer Animal Health Veterinary Specialty Team. “We believe new data presented at WCVD will enable veterinarians to think about the pathobiology of allergic skin diseases in different ways. These studies provide evidence that will guide research into new therapies that target these disease pathways, which are involved in a number of veterinary dermatological conditions.”

According to Sousa, these new pathways also are described in an article—“Current Understanding of the Pathophysiologic Mechanisms of Canine Atopic Dermatitis”—in the July 15 edition of the Journal of the American Veterinary Medical Association (Marsella R, Sousa C, Gonzales A, Fadok V. JAVMA. Jul. 15, 2012; 241(2): 194-207).

Sousa said these new data demonstrate Pfizer’s ongoing focus on veterinary dermatological research to identify new, much-needed treatment options for allergic skin conditions.

“Good dermatologic health and skin care are critically important pieces of the overall pet wellness experience; data shows four out of the top five reasons for seeing a companion animal veterinarian are related to a dermatologic condition,” Sousa said. “With the presentation of this data and other company initiatives, Pfizer Animal Health is working to advance the understanding of dermatology and ultimately give veterinarians the ability to treat allergic skin conditions in new ways.”

About Pfizer Animal Health

Pfizer Animal Health, a business unit of Pfizer Inc, is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic tests. We work to assure a safe, sustainable global food supply from healthy beef and dairy cattle, swine, poultry, sheep and fish while helping dogs, cats and horses live healthier longer lives. We strive to be the animal health company that provides full healthcare solutions to veterinarians, livestock producers, and pet owners. To learn more, visit https://animalhealth.pfizer.com.


For further information, Contact:
Deron Johnson
Pfizer Animal Health
Emily Dahlbeck